Keywords
Right to Health. Health Policy. Marketing of product. Sanitary Surveillance.
DOI:
https://doi.org/10.17566/ciads.v5i0.269How to Cite
1.
Analysis of judgments delivered by TJDFT on unregistered medicines. Cad. Ibero Am. Direito Sanit. [Internet]. 2016 Dec. 30 [cited 2026 Feb. 11];5:8-25. Available from: https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/269
Abstract
This article is general theme analysis on the provision of medicines no national registry at TJDFT in the years 2013-2015. Has so systematized the arguments of decisions and their use of the foundations of the preliminary injunction suspension (STA) 175 the Supreme Court (STF) and the utterances of the National Council of Justice (CNJ) by either party to the process, from analytical description of qualiquantitativos data. It was found of respondent’s judgments, the grounds for the decision STA 175 and statements provided the basis for granting the medicine without national registry on behalf of the user, even without national evidence about their effectiveness and safety - which occurred in 62 % of the studied cases.Authors retain the copyright to their works and grant the Cadernos Ibero-Americanos de Direito Sanitário (CIADS) the right of first publication.
All published articles are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits use, distribution, and reproduction in any medium, provided that the original authorship and the source of publication are properly cited.